Skip to content

Research on the development of the iPS cell stock derived from voluntary HLA homozygoues donor who have donated bone marrow etc.

Research on the development of the iPS cell stock derived from voluntary HLA homozygoues donor who have donated bone marrow etc. - Development of iPS cell stock from bone marrow transplant donors

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016026
Enrollment
20
Registered
2015-01-15
Start date
2015-02-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult

Interventions

None listed

Sponsors

Center for iPS Cell Research and Application (CiRA), Kyoto University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Voluntary, non-remunerated, healthy donors who have donated bone marrow etc. 2)Individuals capable of giving voluntary, informed consent in writing

Exclusion criteria

Exclusion criteria: 1)Enrolling related studies of generating iPSC banks 2)The following viral infection: Hepatic Virus B Hepatic Virus C Human Immunodeficiency Virus Human T-cell leukemia virus Human parvovirus B19 Cytomegalovirus 3)The following microbial infection: Treponema pallidum West Nile Virus Chlamydiaceae Genus Neisseria Mycobacterium Malaria parasites(Plasmodium spp.) Babesia Trypanosoma cruzi Leishmania Trypanosoma brucei 4)Malignant neoplasm 5)Transmissible spongiform encephalopathy (including suspected case), Dementia or cognitive impairment, Stroke, Seizure 6)The following conditions: Particular or genetic/hereditary disorders Severe or uncontrolled metabolic or endocrinal disorders Connective tissue diseases Severe or uncontrolled hematologic diseases Severe or uncontrolled hepatic disorders

Design outcomes

Primary

MeasureTime frame
Charactrization of iPS cells derived from HLA homozyougous donor.

Countries

Japan

Contacts

Public ContactAyumiMatsunaga

Center for iPS Cell Research and Application (CiRA), Kyoto University Medical Application Promotion Office

ips-promotion@cira.kyoto-u.ac.jp075-366-7008

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026